Who invested in Garuda Therapeutics?
Garuda Therapeutics's investors include OrbiMed, Cormorant Asset Management and Alexandria Venture Investments.

United States · Series A startup
Funding summaryUpdated 26 Oct 2026
$50Mraised across 1 round since 2025, from 1 source
Garuda Therapeutics's investors include OrbiMed, Cormorant Asset Management and Alexandria Venture Investments.
Garuda Therapeutics has raised $50M across 1 round since 2025.
Garuda Therapeutics's most recent round was a Series A of $50M in Mar 2025.
Its most recent round, $50M in Mar 2025, is also its largest on record.
Garuda Therapeutics's first round on record, in Mar 2025, was backed by OrbiMed, Cormorant Asset Management and Alexandria Venture Investments.
Garuda Therapeutics's latest named round is a Series A, in Mar 2025.
Garuda Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.